Yousif Capital Management, LLC Enanta Pharmaceuticals Inc Transaction History

Yousif Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$38.82 - $54.59 $80,473 - $113,165	-2,073 Reduced 17.89%	9,516 $384,000
Q4 2022 Jan 09, 2023	SELL	$40.77 - $53.73 $138,618 - $182,682	-3,400 Reduced 22.68%	11,589 $0
Q3 2022 Nov 04, 2022	BUY	$48.29 - $71.27 $30,470 - $44,971	631 Added 4.39%	14,989 $777,000
Q2 2022 Aug 01, 2022	SELL	$38.13 - $76.93 $80,797 - $163,014	-2,119 Reduced 12.86%	14,358 $679,000
Q1 2022 May 12, 2022	BUY	$56.06 - $74.11 $24,946 - $32,978	445 Added 2.78%	16,477 $1.17 Million
Q4 2021 Jan 31, 2022	BUY	$60.19 - $97.37 $964,966 - $1.56 Million	16,032 New	16,032 $1.2 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.